Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice

Chemical Research in Toxicology

Volumn 12, Issue 11, 1999, Pages 1110-1116

  Sumner, Susan C J ^a   Fennell, Timothy R ^a   Moore, Timothy A ^a   Chanas, Brian ^b   Gonzalez, Frank ^c   Ghanayem, Burhan I ^b  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOBENZOTRIAZOLE; ACRYLAMIDE; ACRYLONITRILE; CYTOCHROME P450 ISOENZYME; EPOXIDE; GLUTATHIONE; PLASTIC; POLYMER;

ANIMAL EXPERIMENT; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CARCINOGENICITY; CONJUGATION; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; MALE; METABOLISM; METABOLITE; MOUSE; NONHUMAN; QUANTITATIVE ASSAY; TOXICITY; URINE LEVEL;

ACRYLAMIDE; ACRYLONITRILE; ANIMALS; CYTOCHROME P-450 CYP2E1; FEMALE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RATS;

ANIMALIA; RODENTIA;

EID: 0032750641     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx990040k     Document Type: Article

References (37)

1. Baus, D. K., Hsu, R. S., Neal, M. W., Santodonato, J., Sugatt, R. H., Bayard, S., Bayliss, D. L., Hiremath, C. B., and Vaughn-Dellarco, V. (1983) Health Assessment Document for Acrylonitrile. Technical Report EPA-600/8-82-007F, U.S. Environmental Protection Agency, Research Triangle Park, NC.
2. International Agency for Research on Cancer. (1994) IRAC monographs on the evaluation of carcinogenic risks to humans. Vol. 60, Some Industrial Chemicals, pp 389-433, International Agency for Research on Cancer, Lyon, France.
3. Miller, M. S., and Spencer, P. S. (1985) The mechanism or acrylamide axonopathy. Annu. Rev. Pharmacol. Toxicol. 25, 643-666.
4. Dearfield, K. L., Abernathy, C. O., Ottley, M. S., Branter, J. H., and Hayes, P. F. (1988) Acrylamide, its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutat. Res. 195, 45-77.
5. Maltoni, C., Ciliberti, A., Cotti, G., and Perino, G. (1987) Experimental Research on Acrylonitrile Carcinogenesis, Princeton Scientific Publishing, Princeton, NJ.
6. Miller, M. J., Carter, D. E., and Sipes, I. G. (1982) Pharmacokinetics of acrylamide in Fischer-344 rats. Toxicol. Appl. Pharmacol. 63, 36-64.
7. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 5, 81-89.
8. Sumner, S. C. J., Selvaraj, L., Nauhaus, S. K., and Fennell, T. R. (1997) Urinary metabolites from F344 rats and B6C3F1 mice coadministered acrylamide and acrylonitrile for 1 or 5 days. Chem. Res. Toxicol. 10, 1152-1160.
9. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 4, 678-687.
10. Langvardt, P. W., Putzig, C. L., Braun, W. H., and Young, J. D. (1980) Identification of the major urinary metabolites of acrylonitrile in the rat. J. Toxicol. Environ. Health 6, 273-282.
11. van Bladeren, P. J., Delbressine, L. P. C., Hoogerterp, J. J., Beaumont, A. H. G. M., Briemer, D. D., Seutter-Berlage, F., and van der Gen, A. (1981) Formation of mercapturic acids from acrylonitrile, crotononitrile, and cinnamonitrile by direct conjugation and via and epoxide intermediate oxidation process. Drug Metab. Dispos. 9, 246-249.
12. Kedderris, G. L., Sumner, S. C. J., Held, S. D., Batra, R., Turner, M. J., Jr., Roberts, A. E., and Fennell, T. R. (1993) Dose-dependent urinary excretion of acrylonitrile metabolites by rats and mice. Toxicol. Appl. Pharmacol. 120, 288-297.
13. Kedderis, G. L., Batra, B., Held, S. D., Loos, M. A., and Teo, S. K. O. (1993) Rodent tissue distribution of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile. Toxicol. Lett. 69, 25-30.
14. Sega, G. A., Generoso, E., and Brimer, P. A. (1990) Acrylamide exposure induces an unscheduled DNA synthesis in germ cells of mice that is correlated with the temporal pattern of adduct formation on DNA. Environ. Mol. Mutagen. 16, 137-142.
15. 14C]acrylamide. Carcinogenesis 16, 1161-1165.
16. Yates, J. M., Fennell, T. R., Turner, M. J., Jr., Recio, L., and Sumner, S. C. J. (1994) Characterization of phosphodiester adducts produced by the reaction of cyanoethylene oxide with nucleotides. Carcinogenesis 16, 277-283.
17. Yates, J. M., Sumner, S. C. J., Turner, M. J., Jr., Recio, L., and Fennell, T. R. (1993) Characterization of an adduct and its degradation product produced by the reaction of cyanoethylene oxide with deoxythimidine and DNA. Carcinogenesis 14, 1363-1369.
18. Solomon, J. J., and Segal, A. (1989) DNA adducts of propylene oxide and acrylonitrile epoxide: hydrolytic deamination of 3-alkyl-dCyd to 3-alkyl-dUrd. Environ. Health Perspect. 81, 19-22.
19. Recio, L., and Skopek, T. (1988) Mutagenicity of acrylonitrile and its metabolite 2-cyanoethylene oxide in human lymphoblasts in vitro. Mutat. Res. 206, 297-305.
20. Hasimoto, K., and Tanij, H. (1985) Mutagenicity of acrylamide and its analogues in Salmonella typhimurium. Mutat. Res. 158, 129-133.
21. Barfknecht, T. R., Mecca, D. J., and Naismith, R. W. (1988) The genotoxic activity of acrylamide. Environ. Mol. Mutagen. 11 (Suppl. 11), XXX-XXX.
22. Calleman, C. J. (1996) The metabolism and pharmacokinetics of acrylamide: Implications for mechanisms of toxicity and human risk estimation. Drug Metab. Rev. 28, 527-590.
23. Guengerich, F. P., Kim, D.-H., and Iwasaki, M. (1991) Role of human cytochrome P450-IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168-179.
24. Linhart, I., Smejkal, J., and Novak, J. (1988) N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine, a new urinary metabolite of acrylonitrile and oxiranecarbonitrile. Arch. Toxicol. 61, 484-488.
25. Müller, G., Verkoyen, C., Soton, N., and Norpoth, K. (1987) Urinary excretion of acrylonitrile and its metabolites in rats. Arch. Toxicol. 60, 464-466.
26. Kedderris, G. L., Batra, B., and Koop, D. R. (1993) Epoxidation of acrylonitrile by rats and human cytochrome P450. Chem. Res. Toxicol. 6, 866-871.
27. Lee, S. S. T., Buters, J. T. M., Pineau, T., Fernandez-Salguero, P., and Gonzalez, F. J. (1996) Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. 271, 12063-12067.
28. U.S. Department of Health and Human Services, National Institutes of Health (1985) Guide of the care and use of laboratory animals. NIH Publication 86-23, National Institutes of Health, Bethesda, MD.
29. Mugford, C. A., Mortillo, M., Mico, B. A., and Tarloff, J. B. (1992) 1-Aminobenzotriazole-induced destruction of hepatic and renal cytochromes P450 in male Sprague-Dawley rats. Fundam. Appl. Toxicol. 19, 43-49.
30. Hasimoto, K., and Aldridge, W. N. (1970) Biochemical studies on acrylamide, a neurotoxic agent. Biochem. Pharmacol. 19, 2591-2604.
31. 14C-acrylonitrile in the rat. J. Appl. Toxicol. 3, 39-47.
32. Rouisse, L., Chakrabarti, S., and Tuchweber, B. (1986) Acute nephrotoxic potential of acrylonitrile in Fischer F-344 rats. Res. Commun. Chem. Pathol. Pharmacol. 53, 347-360.
33. Vodicka, P., Gut, I., and Frantik, E. (1990) Effects of inhaled acrylic acid derivatives in rats. Toxicology 65, 209-221.
34. Lewis, D. F. V., Loannides, C., and Parke, D. V. (1998) Cytochrome P450 and species differences in xenobiotic metabolism and activation of carcinogen. Environ. Health Perspect. 106, 633-641.
35. Wu, X., Amos, C. I., Kemp, B. L., Shi, H., Jiang, H., Wa, Y., and Spitz, M. R. (1998) Cytochrome P450 2E1 polymorphisms in lung cancer in minority populations. Cancer Epidemiol., Biomarkers Prev. 7, 13-18.
36. Hildesheim, A., Anderson, L. M., Chen, C. J., Cheng, Y. J., Brinton, L. A., Daly, A. K., Reed, C. D., Chen, I. H., Caporaso, N. E., Hsu, M. M., Chen, J. Y., Idle, J. R., Hoover, R. N., Yang, C. S., and Chhabra, S. K. (1997) CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J. Natl. Cancer Inst. 89, 1207-1212.
37. Ghanayem, B. I., Sanders, J. M., Chanas, B., Burka, L. T., and Gonzalez, F. J. (1999) The role of cytochrome P450 CYP2E1 in methacrylonitrile metabolism and disposition. J. Pharmacol. Exp. Toxicol. (in press).